Jason A. Okazaki

CIK: 0001807214

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)2 (50.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (50.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

ASMB

ASSEMBLY BIOSCIENCES, INC.

DirectorOfficer

Discretionary Trading P&L

Holdings

Transaction History (4 total)

ASMB
ASSEMBLY BIOSCIENCES, INC.
Mar 29, 2026
Award(A)
Direct
50.8K shares-
ASMB
ASSEMBLY BIOSCIENCES, INC.
Mar 31, 2025
Sale(S)
Direct
355 shares at avg. $9.85$3K
ASMB
ASSEMBLY BIOSCIENCES, INC.
Mar 29, 2025
Award(A)
Stock Option (right to buy)
Direct
71.1K shares-
ASMB
ASSEMBLY BIOSCIENCES, INC.
Oct 3, 2024
Sale(S)
Direct
197 shares at avg. $14.81$3K

		Type	Shares	Price		Ownership
Mar 29, 2026	ASMB ASSEMBLY BIOSCIENCES, INC.	Award(A)	50,750	-	$0	Direct
Mar 31, 2025	ASMB ASSEMBLY BIOSCIENCES, INC.	Sale(S)	355	$9.85	$3,496	Direct
Mar 29, 2025	ASMB ASSEMBLY BIOSCIENCES, INC.	Award(A) Stock Option (right to buy)	71,100	-	-	Direct
Oct 3, 2024	ASMB ASSEMBLY BIOSCIENCES, INC.	Sale(S)	197	$14.81	$2,918	Direct

1-4 of 4 transactions

About Okazaki Jason A

Okazaki Jason A (SEC CIK 0001807214) files insider reports with the SEC as CEO and President of ASSEMBLY BIOSCIENCES, INC. (ASMB).

Signal8 holds 3 ownership filings by Okazaki Jason A, all Form 4s, filed between Oct 4, 2024 and Jun 5, 2026. Those filings report 4 transactions, from Oct 3, 2024 to Mar 29, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Okazaki Jason A's filings is in SOUTH SAN FRANCISCO, CA.

Recent filings by Okazaki Jason A

Mar 29, 2026: Grant or award of ASMB shares (Form 4, code A).
Mar 31, 2025: Open-market sale of ASMB shares (Form 4, code S).
Mar 29, 2025: Grant or award of ASMB derivative securities (Form 4, code A).
Oct 3, 2024: Open-market sale of ASMB shares (Form 4, code S).

Other insiders filing for ASSEMBLY BIOSCIENCES, INC. (ASMB)

Bjorkquist Jeanette M, PFO and PAO
Gaggar Anuj, Chief Medical Officer
White Nicole S, Chief Manufacturing Officer
McHutchison John G, Director
Mahony Susan, Director
Johnson-Pratt Lisa, Director

How to read Form 4 transaction codes